Good glycemic control during T2DM management is therefore necessary to reduce the level of PAI-1 in the plasma and this would eventually lower the risk of cardiovascular disease onset in these individuals [15]. The gene discussed is SERPINE1; the disease is type 2 diabetes mellitus.